Researchers figure out what's caused devastating sea star epidemic
In 2013, something began ravaging sea stars along the West Coast, turning them into decaying, fragmented carcasses. Over the next few years, the wasting disease (SSWD) killed billions of animals along the shore, transforming entire marine ecosystems. A network of researchers formed to focus on recovery.
One species was hit especially hard: Pycnopodia helianthoides, more commonly known as the sunflower sea star. Scientists estimate the global population plummeted by 94% since 2013. California alone lost about 99% of its sunflower sea stars. For over a decade, nobody knew what was responsible.
In their paper in Nature Ecology & Evolution, researchers have now identified the culprit behind the devastating epidemic — and with it, a path forward for restoration.
'This was a big deal for us,' said Alyssa Gehman, a marine disease ecologist at Hakai Institute and the University of British Columbia and senior author on the study. 'When we started these experiments, I knew we would learn more, but I honestly wasn't convinced we would actually find the causative agent of disease.'
The breakthrough came during a routine meeting between Gehman and two collaborators, Grace Crandall and Melanie Prentice. They had recently tested whether heat-treated coelomic fluid — the internal body fluid of a sea star — could still trigger the disease when injected into a healthy sea star. When it didn't, and the injected sea stars stayed healthy, it confirmed that the disease was being caused by something that was alive.
To find out what that "something" was, the team turned to a set of techniques that reveals which genes are being expressed by what microorganisms. When they compared healthy and infected animals, one group consistently stood out—the Vibrios, a type of bacteria commonly found in marine environments.
Knowing there are many Vibrios, the researchers were curious whether the wasting sickness could be tied to one in particular. Prentice ran the species-level analysis, and the result floored them.
'The whole list was Vibrio pectinocida. And it was in all of our six stars and it was in none of our controls,' Gehman said. It was "mind-blowingly clear" that this bacteria was causing the disease, she said.
For California's kelp forests, and the conservation groups trying to save them, this news is a major turning point.
Sunflower sea stars are considered a keystone species, meaning they are critical in regulating the stability and diversity of their ecosystems. One of their most important roles is controlling purple sea urchin populations, a species with a notoriously voracious appetite.
'They can mow down a kelp forest and then actually remain in that ecosystem without a food source,' said Prentice, a marine biologist and study co-author. 'They enter almost like a zombie state until the kelp regrows, and then they eradicate it again.'
Sunflower sea stars used to prey on the urchins, keeping them in check. But when wasting disease effectively wiped out their main predator, the sea urchins exploded in number, decimating kelp forests and transforming once-lush underwater habitats into so-called 'urchin barrens.'
'Kelp forests are the most important ecosystem on our coast because they house over 800 species of animals,' said Nancy Caruso, marine biologist and founder of the nonprofit Get Inspired. 'Essentially, they're the condos and apartment complexes of the animals that live on our coastline. When they disappear, the animals have no place to live.'
Kelp forests also filter water, store carbon, and protect coastal communities from storms and erosion, making them an ally in addressing climate change, Prentice said.
Since the 2013 outbreak, areas like Northern California have lost more than 95% of their kelp forest cover. Several sites are still considered ecological collapse zones.
Some scientists trying to recover sunflower sea stars see the finding as a strong guide for future research — and efforts to boost the decimated keystone species.
For example, it could help address concerns California wildlife officials have had that stars bred in captivity might have the disease and carry it into wild waters if they are moved, conservationists said.
Prentice is currently developing something similar to a COVID rapid test that could help screen animals and seawater for the presence of Vibrio pectinocida before they're introduced into the ocean. That beats the cumbersome process of monitoring them to make sure they're healthy enough to be released.
'That's going to be powerful not just for research, but for management,' she said. 'Now we can actually test animals before we move them, or test the water at a potential outplanting site and say, is this a good place for reintroduction?'
Researchers also plan to investigate whether certain stars are resistant to the disease, opening the door to breeding animals that are more resilient. Could exposing them to a low dose of the disease do the trick?
Already there have been promising strides in conservation.
Starting in 2019, Jason Hodin, a senior research scientist at the University of Washington's Friday Harbor Laboratories, spearheaded an effort to see if the hefty stars could be raised in captivity. They could, and the success paved the way for a network of scientists trying to recover the species.
Last year, his team became the first (and currently only) to unleash lab-bred stars into the ocean, dispatching 10 one-year-olds and 10 two-year-olds near the dock of their lab on San Juan Island. None have been seen sick or dying. At least three of the two-year-olds were spotted just a few months ago.
It's 'not only showing that the stars can thrive in the wild, but that if you put them into an area that they like, then they stick around,' he said.
Now he's hoping for approval from Washington's wildlife agency to release stars in a small urchin barren developing on the west side of the island where his lab is located. The idea is to see if introducing them where urchins have taken over, and where the kelp is getting hit, can help restore the kelp.
That work could begin this fall.
Scientists in California are moving in the same direction, but haven't yet planted stars in the wild.
Researchers with the Nature Conservancy may release stars in cages in Monterey Bay as soon as September, replicating a step Hodin's team took before sending them out on their own. They're waiting on approval from the California Department of Fish and Wildlife.
There also have been hopeful sightings of wild stars in California waters. Recently, a sunflower sea star was spotted in Sonoma County, which Hodin estimated is the furthest south anyone has spotted them in seven years.
'It takes a lot of stars to make a healthy population, so just having a few around isn't necessarily enough to get a good sort of population going,' Hodin said, 'but at least it's a sign that the species is still around and that with some assistance, we might be able to bolster these populations.'
At the Aquarium of the Pacific in Long Beach, which cares for some of the surviving sunflower stars, the new findings could help reshape priorities.
'It sharpens our focus on what it might take to reintroduce these animals in a way that is thoughtful, informed, and sustainable,' said Johnathan Casey, the aquarium's curator of fish and invertebrates.
'With each new piece of the puzzle, we feel we're getting closer to a future where sunflower stars can once again thrive along our coastline.'
Sunflower sea stars used to be everywhere — on sand, rocks, kelp beds, and seagrass beds. For Gehman, that's the point. She hopes the findings help people realize that even the most abundant species can disappear very quickly.
This story originally appeared in Los Angeles Times.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
29 minutes ago
- Medscape
Lecanemab Preserves Memory Over 4 Years in Early AD
Continuous treatment with lecanemab (Leqembi, Eisai/Biogen) demonstrated sustained disease-modifying benefit over 4 years in patients with early-stage Alzheimer's disease (AD) enrolled in the open-label extension of the phase 3 CLARITY AD trial. Through 4 years, lecanemab 'meaningfully' delayed progression to dementia stage of disease compared to untreated observational cohorts, said study investigator Christopher van Dyck, MD, Yale University School of Medicine, New Haven, Connecticut. With 4 years of treatment, 'there is in the vicinity of a full year's time saved' in early-stage disease. In addition, more than half of patients in the low tau subgroup showed improvement in cognitive function over time, van Dyck added. The results were presented on July 30 at the Alzheimer's Association International Conference (AAIC) 2025. Widening Benefit Over Time The core CLARITY AD trial included 1795 adults with mild cognitive impairment or early AD and confirmed amyloid pathology in the brain. Treatment consisted of IV infusions of lecanemab 10 mg/kg biweekly (n = 898) or matching placebo (n = 897). After 18 months of treatment, lecanemab slowed cognitive and functional decline, as measured by the Clinical Dementia Rating-Sum of Boxes (CDR-SB), by 27% compared with placebo — an absolute difference of 0.45 points ( P = .00005). To provide context, a change from 0.5 to 1.0 on the CDR score domains of memory, community affairs, and home/hobbies reflects a shift from mild impairment to loss of independence. Of the patients who completed the core 18-month study, 95% elected to continue in the open-label extension study, with 478 patients treated for 4 years. Some of these participants transitioned to once-monthly intravenous (IV) infusions, consistent with the FDA-approved regimen, and some transitioned to subcutaneous injections, a regimen currently under review by the FDA. Over 3 years of treatment, including both the core study and the open-label extension, lecanemab demonstrated a reduction in cognitive decline of 1.01 points on the CDR-SB compared to the expected decline observed in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, van Dyke reported. This benefit grew more pronounced after 4 years, with a reduction of 1.75 points compared to natural history. Similarly, when benchmarked against the expected decline in the BioFINDER cohort, lecanemab showed a reduction of 1.40 points at 3 years and 2.17 points at 4 years. Through 4 years, lecanemab reduced the relative risk of progression to next disease stage by 34% compared with ADNI; 53% of lecanemab-treated patients progressed to next disease stage vs 70% of those in the ADNI cohort. Lecanemab also reduced the relative risk of progression to dementia stage by 56%; 19% of lecanemab-treated patients progressed to dementia vs 37% of ADNI patients. Earlier Treatment Better Among participants in the tau PET substudy who had low tau levels, 69% showed improvement or no decline and 56% showed improvement from baseline on the CDR-SB after 4 years of lecanemab. Similar results were seen on the AD Assessment Scale-cognitive subscale-14; 51% of patients showed improvement or no decline, and 51% showed improvement. Likewise, on the AD Cooperative Study-Activities of Daily Living Scale for Mild Cognitive Impairment, 64% of patients showed improvement or no decline, and 58% showed improvement. These findings suggest that starting and maintaining treatment with lecanemab in early-stage AD may help slow clinical decline and may provide sustained benefits over the long term, van Dyck said. No new safety signals were observed in the open-label extension phase with continued lecanemab treatment over 4 years. 'Most all of the adverse events actually go down in frequency over time, and none of them go up,' he said. Rates of amyloid-related imaging abnormalities (ARIA) decreased after the initial 12 months and remained consistent throughout four years of continuous treatment. Rates of ARIA related to edema (ARIA-E) were 13% at less than 12 months and declined to 1% at 36-48 months. Rates of ARIA related to hemorrhage (ARIA-H) were 15% at less than 12 months and 9% at 36-48 months. 'Exciting' Long-Term Data Reached for comment, Rebecca M. Edelmayer, PhD, vice president of scientific engagement for the Alzheimer's Association, told Medscape Medical News it's 'exciting to see that patients continue to show less decline and potentially even improvement in their clinical scores over time' and that the safety profile is 'consistent over time without any new types of safety events.' Edelmayer also noted that the open-label extension data from CLARITY-AD are in line with other 'real-world' data presented at AAIC 2025 from clinics using lecanemab that have demonstrated 'fairly similar safety and efficacy patterns.' Also providing perspective, Howard Fillit, MD, co-founder and chief science officer of the Alzheimer's Drug Discovery Foundation, noted that the analysis didn't have a stable control group, so the comparisons lean on historical data. But the fact that some patients improved or remained stable over time with continued lecanemab dosing is a 'major advance.' 'It's actually pretty amazing because not only has this historically been thought of as a chronic, uniformly progressive and ultimately fatal disease, but we never really thought that there would be a drug, at least I didn't, that would actually improve patients on a disease-modifying basis as this drug seems to do,' Fillit, who wasn't involved in the study, told Medscape Medical News . Fillit noted that the risk-benefit profile for lecanemab in this open-label study is 'fairly favorable. The rate of serious side effects is quite low, and I think this kind of study can help allay some of those fears about side effects.' He also noted that having a subcutaneous dosing option or lecanemab (if approved) will be a 'game changer' enabling at-home dosing and reducing the burden and inconvenience of having to go to a center to get an infusion of lecanemab. The FDA is set to decide on whether or not to approve the company's biologics license application for lecanemab subcutaneous autoinjector later this month.


Washington Post
31 minutes ago
- Washington Post
Asking Eric: Living with Alzheimer's leads to social isolation
Dear Eric: I was diagnosed some years ago with Alzheimer's. My husband of 45 or so years is wonderful but even he and many of my friends do not understand that I no longer have choices. I know they all mean well, but I have always been a very social person. I love to sing, having taken two years of voice lessons. I love to dance and watch movies, do jigsaw puzzles, word search puzzles and more. As I no longer drive, thank God, there are days when I do not see or hear from anyone. I know lots of people, and I get lonely and sometimes cry. I have come to terms with Alzheimer's. It is the lack of social events that brings me down. I am lonely. What do you suggest? — Wanting Company Company: I'm so sorry to hear that you're lonely. It doesn't have to be this way. Illnesses like Alzheimer's can be isolating, but there are ways that your friends and your husband can show up for you. Start by writing down a list of social connections that you're missing and share it with your husband. Ask him to help by thinking through alternatives or modifications that meet you where you are. You and your care team know your capacity. While some things might not be workable anymore, prompting your husband to think creatively might open some new doors for you. As you write, he means well, but it would appear he's not fully grasping some of the most difficult parts of your experience. This isn't your problem to solve alone, of course. But giving your husband — and, perhaps, close friends — concrete ways they can show up for you may make them better advocates and give you back some of the connection you're seeking. Additionally, you may want to make use of an Alzheimer's support group — online or in person. You can find great resources at Not only do these groups connect you with people who understand what you're going through, but they'll also provide meaningful social connections. Dear Eric: We've had some improvements done on our home lately, and for each job I would get quotes from two different contractors for comparison. There would be the typical friendly back-and-forth between us and the contractors as we work out the details of their proposals. My husband and I then go over the quotes and make our selection of contractors. I always follow up with the contractor we do not go with, thanking them for their time and their quote and offering a very short explanation (always politely worded) about why we went with the other contractor (price; lead time; etc.) as I think they would want some feedback as to why they weren't chosen. These follow-ups are invariably met with radio silence. I understand that the contractor we did not go with has spent time with us which did not ultimately lead to a sale, which is undoubtedly disappointing for them. But as consumers, my husband and I need to make the best choice of where and how we spend our money, especially on big-ticket home improvements costing thousands of dollars. Am I wrong to expect any sort of reply from a contractor after declining their quote? If I go into a store and ultimately do not end up buying something, I am 100 percent more likely to return to the store or recommend the store to someone else if I hear 'thanks for coming' or 'have a good day' as I am leaving. I appreciate their good will. If the contractors we don't go with would even reply with a stock email saying that they hope they can work with us on a future job, I would definitely consider them again. But being ignored just doesn't sit right with me. Isn't at least an acknowledgment of our final communication in order? Or am I expecting too much from a contractor who didn't get our business? — Confused Homeowner Homeowner: Having worked with my share of contractors, I can attest it can be difficult to get and hold their attention sometimes. And I get it — every moment they spend replying to an email or doing a consultation is a moment they're not billing on a project. It's a volume game. And it's different from other sales jobs, like the insurance agent who checks in every year. So, grant them a little grace, even if this particular touch point is a little shortsighted. It is in their best interest to end the interaction on a good note. You're paying for craftsmanship and skill, and part of that skill involves good communication. But, if you liked other aspects of their work and wish to hire them in the future, proceed with caution but don't let this deter you too much. (Send questions to R. Eric Thomas at eric@ or P.O. Box 22474, Philadelphia, PA 19110. Follow him on Instagram and sign up for his weekly newsletter at 2025 Tribune Content Agency, LLC.
Yahoo
31 minutes ago
- Yahoo
If you feel the weather in your bones, this might be why
Some people don't need a weather app - they feel the forecast in their bones. A storm rolls in and so do throbbing heads, aching joints and mood drops. For years, this phenomenon was dismissed as imagination or coincidence. Now, with sharper tools and larger datasets, more researchers are taking weather-related symptoms seriously. As former Agriculture Department chief meteorologist Albert Peterlin put it: 'It's not the weather. It's the change in weather that causes stress.' Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. Sudden swings in atmospheric pressure, humidity and temperature can lower blood oxygen saturation, the amount of oxygen your red blood cells carry, while also triggering hormonal fluctuations and cardiovascular strain - biological changes many people experience before a storm breaks, according to researchers. Falling pressure activates the autonomic nervous system and heightens pain sensitivity in people with chronic conditions, according to studies in Brain Research Bulletin and PLoSOne. The nervous system's fight-or-flight response has been linked to increased anxiety and disrupted sleep. The term for this emerging field is meteoropathy: the study of physiological reactions to environmental changes, especially barometric shifts, that disrupt circulation and rattle the nervous system. Meteoropathic illness is not yet a formal diagnosis, but more scientists are finding evidence for it. 'Doctors have long minimized these complaints as subjective,' says Sarah Mulukutla, a neurologist and adjunct professor at Yale. 'But that doesn't mean imaginary.' Evidence shows that atmospheric instability influences hormone levels, shifts that affect how pain is processed and may explain migraine attacks, joint stiffness and fatigue. - - - Cumulative effects of weather stress Pain doctors are witnessing these effects firsthand. Pavan Tankha, who leads pain recovery at the Cleveland Clinic, says chronic discomfort often worsens during weather instability. One of his patients experiences intense pain flare-ups during spring storms. 'We're observing a weather-sensitive pain phenotype,' or patients who are sensitive to atmospheric swings, Tankha says. 'These effects aren't random. They're cumulative,' says Vincent Martin, director of the University of Cincinnati's Headache and Facial Pain Center. His team found that lightning within 25 miles of a home increases migraine risk by 31 percent. Both rising and falling air density can provoke migraines and tension headaches. A 2023 Japanese study using a barometric pressure-tracking app analyzed over 336,000 headache events alongside weather records. It found that pressure drops, spikes in humidity and rainfall are strongly associated with increased headaches, confirming what many long suspected. Thanks to apps, symptom monitoring is getting smarter. Users log symptoms alongside atmospheric data, and the app learns their storm signature - a unique pattern of weather changes, such as rising pressure or dropping temperature, linked to how their body responds. The personalized approach is catching on in the United States. Peterlin built on that model, creating three-day forecasts and collaborating with pharmaceutical teams on weather-based treatments. Wearable fitness and health technology products like the Apple Watch and Whoop help researchers map the body's invisible reactions to weather in real time. According to Artificial Intelligence Review, wearable sensors can now detect early signs of cardiovascular strain, stress and even mood instability. So, what's happening inside the body? As storms approach, air weight declines and humidity rises. Pain receptors, or nerve endings in joints, muscles and tissues that detect stress, pressure or temperature shifts, send signals through the spine to the brain, where pain and emotion register. The receptors may fire in response to shifts in intracranial pressure sensed by the brain, sinuses and carotid arteries. 'Even slight shifts disrupt balance,' says UCLA neurologist Alan Rapoport, especially for migraine sufferers. (Some 12 percent of people in the United States, primarily women, are said to experience migraines.) A broader view reveals just how much these fluctuations affect us. The State of Global Air report connects climate-driven changes in air quality, temperature and humidity to increased health risks across systems. The bigger the change, the stronger the body's response. 'I don't need to check the forecast. I feel it in my head,' says Susan Cucchiara, a New York-based naturopathic doctor. She hydrates, walks and supplements with magnesium. 'It's about supporting your whole system.' Others echo that sentiment. Laurie Krupa, a patient of Cucchiara's in New Jersey, says before storms, 'pain would flare in my knees, hips and whole body, not just my head.' Today, she finds relief through movement, minerals and nutrition. Weather can hit us hard. Cold fronts, low pressure and damp air may cause tissues to swell and joints to stiffen. The Arthritis Foundation notes that many people with arthritis experience flare-ups during weather changes, particularly when humidity rises or air pressure drops. The Annals of Medicine linked these shifts to increased osteoarthritis pain. Animal research also indicates that high humidity increases inflammatory cytokines, exacerbating joint discomfort. 'Stress, mood and inflammation all interact,' says Terence Starz, retired professor of medicine at the University of Pittsburgh. He notes that tools like the Weather & Arthritis Index help patients anticipate and manage pain episodes. Even the brain isn't immune. The Journal of Physiology reports that high altitude can alter cerebral blood flow. Changes in air density also occur in pressurized flights and incoming storms. 'When air gets lighter, the brain can swell,' which contributes to headaches, says Rapoport. Those most vulnerable usually have a family history of migraine, often compounded by insomnia, stress or hormonal shifts. Baltimore psychologist Andy Santanello offers a deeper insight: 'Weather used to mean danger: cold, scarcity, stress. Our nervous system evolved to react.' The body still carries that ancient imprint. The weather-health connection isn't new. In 1947, physician William F. Petersen proposed that environmental stressors could cause headaches - a theory once dismissed is now supported by neuroscience, real-time data and AI. 'Even Hippocrates wrote about this,' says Peterlin, the former USDA meteorologist. 'Now science is finally proving it.' - - - Help for managing symptoms The weather may be unpredictable, but your body can learn to move with it. Experts recommend: Keep a journal. Tracking your symptoms daily alongside weather patterns may help predict flare-ups. 'With patterns comes predictability,' says Rapoport. Hydrate and supplement. Rapoport also recommends magnesium and riboflavin (Vitamin B2) to reduce migraine frequency. Talk to your doctor. Move gently. Tai chi, walking and yoga improve circulation and joint flexibility. Starz advises staying active but listening to your pain cues. Practice mindfulness. Breathwork and meditation help regulate the nervous system. Mulukutla uses both in treating chronic pain. Use wearables. Tools like the Apple Watch, Whoop, Migraine Mentor and N1-Headache help track patterns and atmospheric shifts. Be proactive. On sensitive days, prioritize sleep, limit stress and reduce screen time. These days, when the weather turns and my body knows it, I stretch, hydrate, rest - and check flights to somewhere sunnier. Related Content Pets are being abandoned, surrendered amid Trump's immigration crackdown The Post exposed this farmer's struggle. Then the USDA called. Kamala Harris will not run for California governor, opening door for 2028 run